Diltiazem-associated Photodistributed Hyperpigmentation
Diltiazem-associated Photodistributed Hyperpigmentation
About this item
Full title
Author / Creator
Publisher
United States: Yale Journal of Biology and Medicine
Journal title
Language
English
Formats
Publication information
Publisher
United States: Yale Journal of Biology and Medicine
Subjects
More information
Scope and Contents
Contents
Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmen...
Alternative Titles
Full title
Diltiazem-associated Photodistributed Hyperpigmentation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087047
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087047
Other Identifiers
ISSN
0044-0086
E-ISSN
1551-4056